Mohammed T. Abou-Saleh

DISTINGUISHING DEPRESSION FROM DEMENTIA 301clinical information gathered ‘‘at the bedside’’ from the patientand his/her family. Various screening instruments and routinelaboratory studies can contribute useful additional information tothe clinician. More advanced studies, such as formal neuropsychologicaltesting, EEG, neuroimaging and genetic testing, canbe helpful in selected patients. In every case, the clinician mustkeep in mind the high concurrence rate of dementia anddepression, the increasing evidence that geriatric depression maybe a prodrome of dementia, as well as the research that points toshared etiologies of dementia and geriatric depression, and thusavoid taking a strict either/or approach.REFERENCES1. Evans DA, Funkenstein HH, Albert MS et al. Prevalence ofAlzheimer’s disease in a community population of older persons:higher than previously reported. J Am Med Assoc 1989; 262: 2551–6.2. Geldmacher DS, Whitehouse PJ. Differential diagnosis ofAlzheimer’s disease. Neurology 1997; 48 (suppl 6): S2–9.3. Lebowitz BD, Pearson JL, Schneider LS et al. Diagnosis andtreatment of depression in late life: consensus statement update. JAm Med Assoc 1997; 278 (14): 1186–90.4. American Psychiatric Association. Diagnostic and Statistical Manualof Mental Disorders, 4th edn (DSM-IV). Washington, DC: AmericanPsychiatric Association, 1994.5. Small GW, Rabins PV, Barry PP et al. Diagnoses and treatment ofAlzheimer’s disease and related disorders. J Am Med Assoc 1997; 278:1363–71.6. US Department of Health and Human Services, Public HealthService, Agency for Health Care Policy and Research. Recognitionand Initial Assessment of Alzheimer’s Disease and Related Dementias.Clinical Practice Guideline No. 19, 1996.7. Patterson CJS, Gauthire S, Howard B et al. The recognition,assessment and management of dementing disorders: conclusionsfrom the Canadian Consensus Conference on Dementia. Can MedAssoc J 1999; 160 (suppl 12): S1–15.8. Doraiswamy PM, Steffens DC, Pitchumoni S, Tabrizi S. Earlyrecognition of Alzheimer’s disease: what is consensual? What iscontroversial? What is practical? J Clin Psychiat 1998; 59 (suppl 13):6–18.9. Blazer D, Bacher JR, Hughes DC. Major depression withmelancholia: A comparison of middle aged and elderly adults. JAm Geriat Soc 1987; 35: 927–32.10. Renolds CF, Hoch CC, Kupfer DJ et al. Bedside differentiation ofdepressive pseudodementia from dementia. Am J Psychiat 1988; 145(9): 1099–103.11. Abrams RC, Alexopoulos GS. Assessment of depression in dementia.Alzheimer’s Dis Assoc Disord 1994; 8 (suppl 1): S227–9.12. Katz IR. Diagnosis and treatment of depression in patients withAlzheimer’s disease and other dementias. J Clin Psychiat 1998; 59(suppl 9): 38–44.13. Folstein MF, Bassett SS, Anthony JC. Dementia: case ascertainmentin a community survey. J Gerontol 1991; 46: M132–8.14. Bravo G, Hebert R. Age- and education-specific reference values forthe Mini-Mental and modified Mini-Mental State Examinationsderived from a non-demented elderly population. Int J GeriatPsychiat 1997; 12: 1008–18.15. Brayne C. Key papers in geriatric psychiatry Mini-Mental State: apractical method for grading the cognitive state of patients for theclinician. Int J Geriat Psychiat 1998; 13: 285–94.16. Agrell B, Dehlin O. The clock-drawing test. Age Aging 1998; 27: 399–403.17. Watson YI, Arfken CL, Birge SJ. Clock completion: an objectivescreening test for dementia. J Am Geriat Soc 1993; 41: 1235–40.18. Kafonek S, Ettinger WH, Roca R et al. Instruments for screening fordepression and dementia in a long-term care facility. J Am Geriat Soc1989; 37: 29–34.19. Ogrocki PK, Welsh-Bohmer KA. Assessment of cognitive andfunctional impairment in the elderly. Neurodegenerative Dementias:Clinical Features and Pathological Mechanisms. New York: McGraw-Hill, 2000.20. Rosenstein LD. Differential diagnosis of the major progressivedementias and depression in middle and late adulthood: a summaryof the literature of the early 1990s. Neuropsychol Rev 1998; 8 (3): 109–67.21. Jacobs DM, Sano M, Dooneief G et al. Neuropsychological detectionand characterization of preclinical Alzheimer’s disease. Neurology1995; 45: 957–62.22. Macknight C, Graham J, Rockwood K. Factors associated withinconsistent diagnosis of dementia between physicians andneuropsychologists. J Am Geriat Soc 1999; 47 (11): 1294–9.23. Carnes M, Smith JC, Kalin NH, Bauwens SF. Effects of chronicmedical illness and dementia on the dexamethasone suppression test.J Am Geriat Soc 1983; 31: 269–71.24. McAllister TW, Ferrell RB, Price TRP, Neville MB. Thedexamethasone suppression test in two patients with severedepressive pseudodementia. Am J Psychiat 1982; 139: 479–81.25. Spar JE, Gerner R. Does the dexamethasone suppression testdistinguish dementia from depression? Am J Psychiat 1982; 139:238–40.26. Raskind M, Peskind E, Rivard MF et al. Dexamethasone suppressiontest and cortisol circadian rhythm in primary degenerative dementia.Am J Psychiat 1982; 139: 1468–71.27. Alexopoulos GS, Young RC, Haycox JA et al. Dexamethasonesuppression test in depression with reversible dementia. PsychiatResid 1985; 16: 277–85.28. McAllister TW, Hays LR. TRH test, DST and response todesipramine in primary degenerative dementia. Biol Psychiat 1987;22: 189–93.29. Shrimanker J, Soni SD, McMurray J. Dexamethasone suppressiontest in dementia and depression. Clinical and biological correlates. BrJ Psychiat 1989; 154: 372–7.30. American Academy of Neurology. Practice parameter for diagnosisand evaluation of dementia. Neurology 1994; 44: 2203–6.31. Lovestone S. Early diagnosis and the clinical genetics of Alzheimer’sdisease. J Neurol 1999; 246: 69–72.32. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose ofapolipoprotein E type 4 allele and the risk of Alzheimer’s disease inlate-onset families. Science 1993; 261: 921–3.33. Krishnan KRR, Tupler LA, Ritchie JC et al. Apolipoprotein E4frequency in geriatric depression. Biol Psychiat 1996; 40: 69–71.34. Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y et al. Dosedependentassociation of apolipoprotein E allele 4 with late-onset,sporadic Alzheimer’s disease. Ann Neurol 1994; 36: 656–9.35. Steffens DC, Plassman BL, Helms MJ et al. A twin study of late-onsetdepression and apolipoprotein E E4 as risk factors for Alzheimer’sdisease. Biol Psychiat 1997; 41: 851–6.36. Klass DW, Brenner RP. Electroencephalography of the elderly. J ClinNeurophysiol 1995; 12: 116–31.37. Perlis ML, Giles DE, Buysse DJ et al. Which depressive symptoms arerelated to which sleep electroencephalographic variables? BiolPsychiat 1997; 42: 904–13.38. Dykierek P, Stadtmuller G, Schramm P et al. The value of REM sleepparameters in differentiating Alzheimer’s disease from old-agedepression and normal aging. J Psychiat Res 1998; 32: 1–9.39. Katzman R. Should a major imaging procedure (CT or MRI) berequired in the workup of dementia? Affirmative view. J Fam Pract1990; 31: 405–10.40. Clarfield AM, Larson EB. Should major imaging procedure (CT orMRI) be required in the workup of dementia? Opposing view. J FamPract 1990; 31: 405–10.41. Steffens DC, Krishnan KRR. Structural neuroimaging and mooddisorders: recent finding, implications for classification and futuredirections. Biol Psychiat 1998; 43: 705–12.42. O’Brien JT, Desmond P, Schweitzer AI et al. Temporal lobe magneticresonance imaging can differentiate Alzheimer’s disease from normalageing, depression, vascular dementia and other causes of cognitiveimpairment. Psychol Med 1997; 27: 1267–75.43. Jack CR, Petersen RC, Xu YC et al. Medial temporal atrophy onMRI in normal aging and very mild Alzheimer’s disease. Neurology1997; 49: 786–94.44. Sheline YI. Hippocampal atrophy in major depression: a result ofdepression-induced neurotoxicity. Mol Psychiat 1996; 4: 298–9.45. Steffens DC, Byrum CE, McQuoid DR et al. Hippocampal volume ingeriatric depression. Biol Psychiat 2000; 48: 301–9.